Role of cyclic GMP in the mechanism of action of nitrovasodilators, endothelium-dependent agents and atrial natriuretic peptide.
Murad
F
F
Department of Medicine, Stanford University, CA.
D000818:Animals; D009320:Atrial Natriuretic Factor / Q000494:pharmacology / Q000502:physiology*; D001685:Biological Factors / Q000502:physiology*; D006152:Cyclic GMP / Q000502:physiology*; D004730:Endothelium, Vascular / Q000502:physiology*; D008954:Models, Biological; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000502:physiology*; D009569:Nitric Oxide; D009574:Nitro Compounds / Q000494:pharmacology; D014665:Vasodilator Agents / Q000494:pharmacology*
D001685:Biological Factors; D009574:Nitro Compounds; D014665:Vasodilator Agents; D009569:Nitric Oxide; D009320:Atrial Natriuretic Factor; D006152:Cyclic GMP